Harare, Zimbabwe

Site Institution
The University of Zimbabwe and its affiliated units

U.S. Institution
Stanford University, Center for Innovation in Global Health

U.S. Based Mentors

David Katzenstein, MD
Professor of Medicine
E-mail: davidkk@stanford.edu



maldonado-yvonneYvonne Maldonado, MD
Professor of Pediatrics and of Health Research and Policy
E-mail: bonniem@stanford.edu



Benjamin Pinsky, MD, PhD
Assistant Professor, Departments of Pathology and Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine



Michele Barry

Michele Barry, MD, FACP
Senior Associate Dean for Global Health
Director, Center for Innovation in Global Health, Professor of Medicine



Local Mentor

HakimJames Hakim, FRCP
Chairman of the Department Medicine, College of Health Sciences
E-mail: jhakim@mweb.co.zw


Dixon Chibanda, MPH, MD, DMH, MMed
Consultant Psychiatrist/ Lecturer
Email: dichi@zol.co.zw



Research Focus
HIV/AIDS, TB, STI, mental health

Site and Background

This site offers a unique “slum” setting caused by past 20 years of political strife that destroyed urban and rural infrastructure. The main collaborating institution is The University of Zimbabwe (UZ) and its affiliated units, which have been active in research implementation and training even during the most difficult economic and political period in Zimbabwe’s history. The University of Zimbabwe Clinical Research Centre (UZCRC) was established in 2001 and has in 16 years executed 12 large clinical trials and several large sub-studies. The Biomedical Research and Training Institute (BRTI) is a holder of several grants from NIH, Wellcome Trust and Medical Research Unit from the mid-90s up to date. Stanford PIs have partnered with UZ through the DAIDS networks, Fogarty training grants and NIH RO-1s with James Hakim, Michael Chirenje, Tsungai Chipato and Peter Mason among other faculty at UZ.

On-going NIAID-supported research focuses on AIDS, TB and STIs as a model slum health problem and aims to: 1) understand the natural history of the disease and determine the effectiveness of community-based interventions and 2) apply translational research approaches in identifying new diagnostics, prevention and treatments.

In addition, an ICORHTA program project supervised by Katzenstein and Mason BRTI has been studying the transmission dynamics of HIV, TB and drug-resistant disease in urban populations. The infrastructure and expertise created by these studies has allowed UZ to secure large investments by PEPFAR, the US CDC and NIH to expand research into additional prevention and treatment interventions. This site also offers strong on-site research mentorship by James Hakim, who is co-PI with Dr. Michele Barry on a 5 year NIH MEPI grant for Novel Education, Clinical Training and Research Collaboration (NECTAR) [RFA-TW-10-0087].